Pharmacokinetic/pharmacodynamic analysis of oral amoxicillin-clavulanic acid against extended-spectrum beta-lactamase producing Escherichia coli in an in vitro bladder infection model: impact on clinical breakpoints
Uropathogens with acquired ESBL-genes can limit effective oral treatment options. Amoxicillin with clavulanic acid can be used as targeted therapy (500/125